CD8A and neoplasm: In HNSCC, the TME is composed of tumor-infiltrating immune cells such as CD4+ and CD8+ T cells, myeloid-derived suppressor cells, and tumor-associated M1- or M2-polarized macrophages (TAMs) that interact with tumor cells to promote or suppress growth [12].